Sreenivasa Rao Kondapally Seshasai

Author

Also Known As

Philip Haycock, S R K Seshasai, S. R. K. Seshasai, S. R. Kondapally Seshasai, S.R. Kondapally Seshasai, S.R. Seshasai, S.R.K. Seshasai, Sreenivasa R K Seshasai, Sreenivasa R Seshasai, Sreenivasa Rao Kondapally Seshasai

Publications

9.7K

Citations

H-Index

Concepts

All Affiliations

St George's, University of London Imperial College London University of Leicester Amgen (Switzerland)Amgen (United Kingdom)

About

Sreenivasa Rao Kondapally Seshasai is an author at St George's, University of London specializing in medicine, cardiovascular disease, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	197
2	Public Health	1	1	19
3	Diabetes	1	1	19
4	Epidemiology	1	1	19
5	Family Medicine	1	1	178

Sreenivasa Rao Kondapally Seshasai

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death Sreenivasa Rao Kondapally Seshasai, Stephen Kaptoge, Alexander Thompson, New England Journal of Medicine	2011	2.7K
Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease Emanuele Di Angelantonio, Pei Gao, Hassan Khan, JAMA	2014	229
Familial hypercholesterolaemia: A global call to arms Antonio J. Vallejo‐Vaz, Sreenivasa Rao Kondapally Seshasai, Della Cole, Atherosclerosis Metabolic SyndromeFamily MedicineLipid DisorderCardiovascular DiseaseHyperlipidemia	2015	178
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration Antonio J. Vallejo‐Vaz, Asif Akram, Sreenivasa Rao Kondapally Seshasai, Atherosclerosis Supplements	2016	112
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe Kamlesh Khunti, Mark D. Danese, Lucie Kutikova, JAMA Network Open	2018	102
Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm Sandeep Bahia, Alberto Vidal‐Diez, Sreenivasa Rao Kondapally Seshasai, British journal of surgery	2016	87
Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK Mark D. Danese, Michelle Gleeson, Lucie Kutikova, BMJ Open	2016	41
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study Mark D. Danese, Michelle Gleeson, Lucie Kutikova, BMJ Open	2017	33
Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary László Márk, Antonio J. Vallejo‐Vaz, István Reiber, Atherosclerosis	2015	29
Statins and risk of incident diabetes – Authors' reply Naveed Sattar, David Preiss, Paul Welsh, The Lancet Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyCardiovascular DiseaseDiabetes	2010	19

Page 1